MannKind

3 Oversold Biotech Stocks Being Snapped up By Insiders
Seeking Alpha
Fri, 03/11/11 - 01:29 pm
MannKind
Seattle Genetics
Theravance
Pomerantz Law Firm Reminds Shareholders of MannKind Corp of Upcoming Deadline
Yahoo/GlobeNewsWire
Sat, 03/5/11 - 12:22 pm
MannKind
lawsuits
Pending FDA Approval Means Mannkind Is Down, But It's Not Out
Seeking Alpha
Thu, 03/3/11 - 08:49 am
FDA
inhaled insulin
MannKind
Afrezza
Biotech Mailbag: BIO CEO Wrap
TheStreet.com
Fri, 02/18/11 - 09:36 am
BIO CEO Conference
Rexahn
Nymox
MannKind
Teva Pharmaceuticals
Somaxon
Medivation
Cell Therapeutics
YM BioSciences
Earnings Setback for MannKind: Frozen in Tracks Over Afrezza?
Seeking Alpha
Tue, 02/15/11 - 09:24 am
earnings
MannKind
Afrezza
inhaled insulin
Mannkind Slashes Staff: Biotech's Latest Tribulations
Seeking Alpha
Mon, 02/14/11 - 11:23 am
MannKind
layoffs
AP Pharma
GSK
Pfizer
Orexigen
Is It Worth Buying the MannKind Dip?
Seeking Alpha
Sun, 02/13/11 - 10:57 am
MannKind
Afrezza
inhaled insulin
49 Days Left - Kahn Swick & Foti, LLC and Former Louisiana Attorney General Remind Investors With Large Financial Interests (Over $100,000) of Lead Plaintiff Deadline in Lawsuit Against MannKind Corp. - MNKD
Yahoo/BusinessWire
Sat, 02/12/11 - 12:57 pm
MannKind
lawsuits
Biotech Optimists Throw In the Towel
Motley Fool
Sat, 02/12/11 - 12:55 pm
biotech
MannKind
Orexigen
Arena Pharmaceuticals
XenoPort
A.P. Pharma
MannKind Shares Plunged: What You Need to Know
Motley Fool
Sat, 02/12/11 - 12:18 pm
MannKind
Afrezza
inhaled insulin
diabetes
Earnings Preview: MannKind
Yahoo/Zacks.com
Mon, 02/7/11 - 11:19 am
earnings
MannKind
Mannkind Shares Popped: What You Need to Know
Motley Fool
Wed, 02/2/11 - 05:22 pm
Afrezza
inhaled insulin
MannKind
5 Drugmakers Headed Back to the Drawing Board
Motley Fool
Mon, 01/31/11 - 06:54 pm
Bydureon
Eli Lilly
Amylin
diabetes
MannKind
Afrezza
InterMune
Esbriet
IPF
Lorqess
Arena Pharmaceuticals
Vivus
Qnexa
A Foursome Of Pharma Earnings Suggests Business Is Still Tough
Investopedia
Mon, 01/31/11 - 05:07 pm
earnings
Abbott Laboratories
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
MannKind
Novartis
Vivus
Inhaled Insulin Maker Still Breathing - MannKind’s future may hinge on deep pockets of owner
LA Business Journal, CA
Tue, 01/25/11 - 12:03 pm
MannKind
inhaled insulin
diabetes
Afrezza
FDA's Second Rejection of Mannkind's Inhaled Insulin Has Investors Worried
Seeking Alpha
Thu, 01/20/11 - 10:11 am
FDA
inhaled insulin
MannKind
diabetes
MannKind’s Inhaled Insulin Fails to Win U.S. Approval
Bloomberg
Thu, 01/20/11 - 09:47 am
inhaled insulin
MannKind
Afrezza
diabetes
2-Star Stocks Poised to Plunge: MannKind?
Motley Fool
Wed, 01/19/11 - 11:10 am
MannKind
Mann doubles down on biotech as Afrezza decision looms
Fierce Biotech
Wed, 01/5/11 - 11:49 am
diabetes
MannKind
inhaled insulin
Afrezza
Biotech 2011 Kickoff Party: Investor Preview
TheStreet.com
Wed, 01/5/11 - 11:09 am
biotech
Celgene
Dendreon
MannKind
Vertex Pharmaceuticals
Genzyme
Ariad Pharmaceuticals
Keryx

Pages